Compare WSM & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WSM | PODD |
|---|---|---|
| Founded | 1956 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 21.0B |
| IPO Year | N/A | 2007 |
| Metric | WSM | PODD |
|---|---|---|
| Price | $211.06 | $286.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 19 |
| Target Price | $199.73 | ★ $367.32 |
| AVG Volume (30 Days) | ★ 1.2M | 629.1K |
| Earning Date | 11-19-2025 | 02-18-2026 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | ★ 10.21 | N/A |
| EPS | ★ 9.11 | 3.45 |
| Revenue | ★ $7,911,905,000.00 | $2,521,800,000.00 |
| Revenue This Year | $2.98 | $32.55 |
| Revenue Next Year | $3.49 | $20.50 |
| P/E Ratio | ★ $23.04 | $83.02 |
| Revenue Growth | 5.10 | ★ 27.11 |
| 52 Week Low | $130.07 | $230.05 |
| 52 Week High | $219.98 | $354.88 |
| Indicator | WSM | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 69.69 | 44.53 |
| Support Level | $203.92 | $275.10 |
| Resistance Level | $212.20 | $299.80 |
| Average True Range (ATR) | 7.06 | 7.48 |
| MACD | 2.15 | 0.77 |
| Stochastic Oscillator | 96.91 | 45.07 |
With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. Namesake Williams-Sonoma (153 stores) offers high-end cooking essentials, while Pottery Barn (183) provides casual home accessories. West Elm (119) is an emerging concept for young professionals, and Rejuvenation (13) offers lighting and house parts. Brand extensions include Pottery Barn Kids and Pottery Barn Teen (45) as well as Mark & Graham and GreenRow. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.